# Kinepict Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kinepict-health

- Industry: Medical Devices & Equipment
- Headquarters: Budapest, Hungary
- Website: www.kinepict.com
- Latest round: Series A (Jul 1, 2016)
- Investors on record: 1

## About

Kinepict Health Ltd. specializes in advanced medical imaging technologies, particularly in small vessel and stenosis imaging, significantly enhancing clinical decision-making and patient care.Kinepict Health Ltd. was founded in 2015 and is headquartered in Budapest, Hungary. The company focuses on developing innovative imaging solutions for medical applications. Krisztián Szigeti serves as both the Founder and CEO. Kinepict has successfully completed two deals, with the most recent funding round occurring on July 1, 2016, where the company raised an undisclosed amount in Series A funding, led by FastVentures.Kinepict Medical Imaging Tool (KMIT) is a pioneering medical imaging technology that focuses on small vessel and stenosis imaging. Its sophisticated imaging system generates high-quality DVA images while significantly reducing the need for iodinated contrast media and X-ray doses. KMIT serves hospitals and healthcare facilities performing critical procedures, such as Uterine Fibroid Embolization and Prostate or Liver Artery Embolization, thus empowering clinicians with precise visualization for effective decision-making in critical limb ischemia cases. The technology is utilized in various markets, particularly in Europe and North America, where there is high demand for advanced imaging solutions.In the most recent year, Kinepict generated revenue amounting to USD 71,757.90, while reporting an EBITDA of USD -319,133.50. The company adopts a direct-to-consumer model targeting healthcare providers requiring advanced imaging solutions through direct sales or partnerships with medical institutions.Kinepict plans to expand its product offerings with upcoming innovations in medical imaging technology slated for launch in 2024. The company is also targeting expansion into additional European and North American markets by 2025. The funds raised during the Series A round in July 2016 will support these initiatives, enabling Kinepict to enhance its product development and market penetration efforts.

## Funding rounds

- Series A, Jul 1, 2016 — FastVentures

## Investors

- FastVentures (https://capitalatlas.ai/funds/fastventures) — Series A